Efficacy and Safety of Insulin Degludec in a Flexible Dosing Regimen vs Insulin Glargine in Patients With Type 1 Diabetes (BEGIN: Flex T1): A 26-Week Randomized, Treat-to-Target Trial With a 26-Week Extension
| Date first appeared online | 31/12/2013 |
| DOI | 10.1210/jc.2012-3249 |
| Authors | Bain S. |
| Journal Name | Journal of Clinical Endocrinology & Metabolism |
| Volume | 98 |